Vigour of CRISPR/Cas9 Gene Editing in Alzheimer’s Disease

Journal Title: Journal of Neuroscience and Neurological Disorders - Year 2018, Vol 2, Issue 2

Abstract

Ailment repairing regiments has turn out to be arduous, despite a plenty of understanding and knowledge acquired in the past relating to the molecular underpinnings of Alzheimer’s disease (AD. Umpteen clinical experiments targeting the fabrication and accumulation have been turned fruitless to fit potency standards. The tests aiming beta-amyloid hypothesis also turned futile making it exigent for further handling tactics. The new emanation of a comparably candid, economical, and punctilious system known as gene editing have showed light in path of cure for AD by CRISPR/Cas9 gene editing. Being a straight approach this procedure has already shown assurance in other neurological disorders too such as Huntington’s disease. This review standpoint the immanent service of CRISPR/Cas9 as a remedial option for AD by aiming on specific genes inclusive of those that induce early-onset AD, as well as those that are substantial risk components for late-onset AD such as the apolipoprotein E4 (APOE4) gene.

Authors and Affiliations

Paul Jes

Keywords

Related Articles

Discrepancy in Microglia and Peripheral Monocytic Cells - A scope in the Pathophysiology of Psychiatric maladies

Broad medleys of research have recognized the microglial activation in perilous psychiatric maladies such as schizophrenia, bipolar disorder, and major depressive disorder. There is a scenario of enlivening of peripheral...

Herpes simplex virus (HSV)-1 encephalitis can induce chronic anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis

Herpes simplex virus (HSV)-1 encephalitis is the most common infectious cause of sporadic encephalitis. Despite treatment with acyclovir, HSV encephalitis is still associated with severe morbidity characterized by persis...

Spinal muscular atrophy counteracted by Agrin biological NT-1654

Spinal muscular atrophy (SMA) is a genetic and gravely disease, portrayed by motor neuron (MN) death, thereby leading to progressive and accelerating muscle fragility, respiratory collapse, and, in the most severe cases,...

A Three approach at one stage to surgical management of Cervical Spondyloptosis after Failed Primary anterior fusion

A 35-year-old female, known case of complete spinal cord injury, presented with cervical pain and neck deformity that interfere with her physiotherapy and occupational therapy. Two years before admission, she had a car a...

Direct Carotid Puncture for Flow Diverter Stent Insertion

Objective: To report our experience of direct carotid puncture and its use in the management of a large and rapidly expanding cavernous aneurysm. Methods: A patient with a cavernous aneurysm that measured 25mm in maximu...

Download PDF file
  • EP ID EP555167
  • DOI 10.29328/journal.jnnd.1001014
  • Views 38
  • Downloads 0

How To Cite

Paul Jes (2018). Vigour of CRISPR/Cas9 Gene Editing in Alzheimer’s Disease. Journal of Neuroscience and Neurological Disorders, 2(2), 47-51. https://europub.co.uk/articles/-A-555167